Display options
Cite
Kairemo K, Kangasmäki A, Bom HS. Comparison of I-131 Biokinetics after Recombinant Human TSH Stimulation and Thyroid Hormone Withdrawal Measured by External Detector in Patients with Differentiated Thyroid Cancer. Chonnam Med J. 2019;55(1):20-24doi: 10.4068/cmj.2019.55.1.20.
Kairemo, K., Kangasmäki, A., & Bom, H. S. (2019). Comparison of I-131 Biokinetics after Recombinant Human TSH Stimulation and Thyroid Hormone Withdrawal Measured by External Detector in Patients with Differentiated Thyroid Cancer. Chonnam medical journal, 55(1), 20-24. https://doi.org/10.4068/cmj.2019.55.1.20
Kairemo, Kalevi, et al. "Comparison of I-131 Biokinetics after Recombinant Human TSH Stimulation and Thyroid Hormone Withdrawal Measured by External Detector in Patients with Differentiated Thyroid Cancer." Chonnam medical journal vol. 55,1 (2019): 20-24. doi: https://doi.org/10.4068/cmj.2019.55.1.20
Kairemo K, Kangasmäki A, Bom HS. Comparison of I-131 Biokinetics after Recombinant Human TSH Stimulation and Thyroid Hormone Withdrawal Measured by External Detector in Patients with Differentiated Thyroid Cancer. Chonnam Med J. 2019 Jan;55(1):20-24. doi: 10.4068/cmj.2019.55.1.20. Epub 2019 Jan 25. PMID: 30740336; PMCID: PMC6351326.
Copy Download .nbib Format: NLM
Share it on

Chonnam Med J. 2019 Jan;55(1):20-24. doi: 10.4068/cmj.2019.55.1.20. Epub 2019 Jan 25.

Comparison of I-131 Biokinetics after Recombinant Human TSH Stimulation and Thyroid Hormone Withdrawal Measured by External Detector in Patients with Differentiated Thyroid Cancer.

Chonnam medical journal

Kalevi Kairemo, Aki Kangasmäki, Hee-Seung Bom

Affiliations

  1. Molecular Radiotherapy & Nuclear Medicine, Docrates Cancer Center, Helsinki, Finland.
  2. Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  3. Finland Radiation Physics, Docrates Cancer Center, Helsinki, Finland.
  4. Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju, Korea.

PMID: 30740336 PMCID: PMC6351326 DOI: 10.4068/cmj.2019.55.1.20

Abstract

The aim of this study was to compare radioactive iodine (I-131) biokinetics after recombinant human TSH stimulation (rhTSH) and thyroid hormone withdrawal (THW) in patients with differentiated thyroid cancer (DTC). External effective dose rates were measured using external detectors and imaged quantitatively at the time of discharge from the isolation wards. We retrospectively analyzed 32 patients who had been diagnosed with DTC, papillary or follicular, and underwent remnant ablation after either rhTSH stimulation (n=22) or THW (n=10). The uptake of I-131 by remnant thyroid tissue was measured from 20.0 cm, 100.0 cm and 200.0 cm distances using a handheld external detector. The remnant thyroid tissue measured by the whole body images two to five days from administration was 10.7+26.0% (range 0.5 to 60.0%). The values measured at 20 cm were best correlated to the thyroid residual uptake measured by SPECT/CT. The half-lives of I-131washout (T1/2) in rhTSH group measured by external detector were shorter than those of THW group. T1/2 becomes longer when it was measured over longer distances. They were 10.9, 12.3 and 13.1 hours at distances of 20, 100, and 200 cm in rhTSH group, respectively. The TWH group showed 12.8, 14.9 and 17.7 hours, respectively. We conclude that I-131 biokinetics can be measured by external detector after high dose I-131 therapy for DTC. It showed that washout of I-131 was faster after rhTSH stimulation than THW, and slower in patients with distant metastasis than those without metastasis.

Keywords: Iodine Radioisotopes; Neoplasm, Residual; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa

Conflict of interest statement

CONFLICT OF INTEREST STATEMENT: None declared.

References

  1. Thyroid. 2001 Sep;11(9):865-9 - PubMed
  2. J Endocrinol Invest. 2002 Jan;25(1):44-52 - PubMed
  3. J Clin Endocrinol Metab. 2004 Aug;89(8):3668-76 - PubMed
  4. J Nucl Med. 2006 Apr;47(4):648-54 - PubMed
  5. Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):260-9 - PubMed
  6. Thyroid. 2008 May;18(5):509-16 - PubMed
  7. Clin Nucl Med. 2009 Jun;34(6):339-42 - PubMed
  8. J Clin Endocrinol Metab. 2010 Jul;95(7):3283-90 - PubMed
  9. Int J Radiat Oncol Biol Phys. 1988 Jun;14(6):1063-75 - PubMed
  10. World J Nucl Med. 2015 Sep-Dec;14(3):144-55 - PubMed
  11. Asia Ocean J Nucl Med Biol. 2013 Spring;1(1):6-13 - PubMed
  12. Asia Ocean J Nucl Med Biol. 2013 Spring;1(1):20-6 - PubMed
  13. Asia Ocean J Nucl Med Biol. 2015 Winter;3(1):26-34 - PubMed
  14. Medicine (Baltimore). 2016 Nov;95(47):e5450 - PubMed
  15. Ann Nucl Med. 2017 Oct;31(8):582-589 - PubMed
  16. J Clin Oncol. 2018 Jun 20;36(18):1831-1839 - PubMed
  17. Nucl Med Commun. 2018 Apr;39(4):283-289 - PubMed
  18. J Nucl Med. 2018 May;59(5):723-725 - PubMed
  19. J Clin Oncol. 2018 Jun 20;36(18):1887-1888 - PubMed
  20. J Nucl Med. 1984 Dec;25(12):1287-93 - PubMed
  21. J Clin Endocrinol Metab. 1983 Jun;56(6):1131-8 - PubMed
  22. Am J Med. 1994 Nov;97(5):418-28 - PubMed
  23. Am J Med. 1976 Jul;61(1):52-8 - PubMed

Publication Types